ID;pdf_name;keyword;page_num;line_num;line_text;token_text
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;1;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;2;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;3;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;4;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;5;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;6;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;7;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;8;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;9;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;10;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;11;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;12;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;13;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;14;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;15;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;16;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;17;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;18;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;19;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;20;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;21;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;22;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;23;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;24;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;25;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;26;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;27;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;28;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;29;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;30;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;31;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;32;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;33;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;34;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;35;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;36;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;37;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;38;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;39;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;40;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;41;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;42;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;43;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;44;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;45;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;46;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;47;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;48;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;49;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;50;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;51;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;52;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;53;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;54;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;55;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;56;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;57;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;58;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;59;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;60;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;61;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;62;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;63;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;64;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;65;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;66;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;67;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;68;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;69;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;70;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;71;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;72;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;73;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;74;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;75;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;76;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;77;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;78;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;79;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;80;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;81;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;82;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;83;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;84;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;85;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;86;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;87;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;88;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;89;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;90;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;91;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;92;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;93;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;94;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;95;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;96;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;97;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;98;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;99;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;100;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;101;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;102;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;103;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;104;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;105;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;106;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;107;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;108;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;109;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;110;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;111;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;112;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;113;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;114;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;115;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;116;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;117;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;118;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;119;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;120;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;121;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;122;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;123;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;124;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;125;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;126;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;127;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;128;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;129;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;130;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;131;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;132;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;133;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;134;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;135;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;136;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;137;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;138;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;139;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;140;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;141;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;142;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;143;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;144;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;145;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;146;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;147;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;148;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;149;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;150;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;151;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;152;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;153;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;154;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;155;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;156;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;157;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;158;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;159;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;160;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;161;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;162;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;163;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;164;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;165;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;166;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;167;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;168;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;169;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;170;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;171;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;172;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;173;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;174;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;175;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;176;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;177;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;178;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;179;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;180;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;181;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;182;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;183;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;184;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;185;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;186;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;187;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;188;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;189;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;190;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;191;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;192;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;193;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;194;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;195;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;196;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;197;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;198;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;199;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;200;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;201;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;202;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;203;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;204;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;205;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;206;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;207;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;208;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;209;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;210;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;211;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;212;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;213;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;214;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;215;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;216;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;217;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;218;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;219;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;220;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;221;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;222;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;223;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;224;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;225;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;226;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;227;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;228;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;229;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;230;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;231;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;232;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;233;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;234;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;235;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;236;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;237;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;238;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;239;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;240;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;241;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;242;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;243;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;244;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;245;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;246;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;247;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;248;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;249;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;250;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;251;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;252;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;253;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;254;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;255;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;256;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;257;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;258;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;259;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;260;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;261;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;262;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;263;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;264;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;265;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;266;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;267;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;268;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;269;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;270;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;271;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;272;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;273;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;274;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;275;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;276;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;277;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;278;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;279;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;280;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;281;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;282;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;283;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;284;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;285;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;286;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;287;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;288;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;289;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;290;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;291;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;292;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;293;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;294;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;295;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;296;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;297;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;298;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;299;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;300;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;301;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;302;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;303;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;304;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;305;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;306;;
1;Genetic variants shape rheumatoid arthritis- specific transcriptomic features in CD4+  T cells through differential DNA methylation,  explaining a substantial proportion of heritability.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;307;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;1;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;2;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;3;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;4;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;5;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;6;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;7;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;8;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;9;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;10;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;11;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;12;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;13;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;14;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;15;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;16;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;17;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;18;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;19;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;20;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;21;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;22;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;23;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;24;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;25;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;26;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;27;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;28;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;29;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;30;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;31;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;32;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;33;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;34;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;35;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;36;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;37;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;38;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;39;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;40;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;41;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;42;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;43;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;44;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;45;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;46;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;47;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;48;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;49;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;50;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;51;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;52;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;53;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;54;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;55;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;56;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;57;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;58;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;59;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;60;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;61;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;62;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;63;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;64;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;65;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;66;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;67;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;68;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;69;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;70;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;71;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;72;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;73;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;74;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;75;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;76;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;77;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;78;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;79;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;80;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;81;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;82;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;83;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;84;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;85;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;86;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;87;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;88;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;89;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;90;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;91;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;92;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;93;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;94;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;95;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;96;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;97;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;98;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;99;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;100;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;101;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;102;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;103;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;104;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;105;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;106;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;107;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;108;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;109;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;110;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;111;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;112;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;113;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;114;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;115;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;116;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;117;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;118;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;119;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;120;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;121;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;122;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;123;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;124;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;125;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;126;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;127;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;128;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;129;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;130;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;131;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;132;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;133;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;134;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;135;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;136;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;137;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;138;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;139;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;140;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;141;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;142;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;143;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;144;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;145;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;146;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;147;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;148;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;149;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;150;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;151;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;152;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;153;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;154;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;155;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;156;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;157;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;158;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;159;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;160;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;161;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;162;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;163;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;164;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;165;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;166;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;167;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;168;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;169;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;170;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;171;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;172;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;173;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;174;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;175;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;176;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;177;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;178;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;179;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;180;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;181;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;182;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;183;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;184;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;185;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;186;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;187;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;188;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;189;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;190;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;191;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;192;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;193;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;194;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;195;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;196;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;197;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;198;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;199;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;200;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;201;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;202;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;203;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;204;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;205;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;206;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;207;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;208;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;209;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;210;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;211;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;212;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;213;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;214;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;215;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;216;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;217;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;218;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;219;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;220;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;221;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;222;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;223;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;224;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;225;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;226;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;227;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;228;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;229;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;230;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;231;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;232;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;233;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;234;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;235;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;236;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;237;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;238;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;239;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;240;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;241;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;242;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;243;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;244;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;245;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;246;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;247;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;248;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;249;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;250;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;251;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;252;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;253;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;254;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;255;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;256;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;257;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;258;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;259;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;260;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;261;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;262;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;263;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;264;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;265;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;266;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;267;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;268;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;269;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;270;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;271;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;272;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;273;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;274;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;275;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;276;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;277;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;278;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;279;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;280;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;281;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;282;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;283;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;284;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;285;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;286;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;287;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;288;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;289;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;290;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;291;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;292;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;293;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;294;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;295;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;296;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;297;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;298;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;299;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;300;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;301;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;302;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;303;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;304;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;305;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;306;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;307;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;308;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;309;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;310;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;311;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;312;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;313;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;314;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;315;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;316;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;317;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;318;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;319;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;320;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;321;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;322;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;323;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;324;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;325;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;326;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;327;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;328;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;329;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;330;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;331;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;332;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;333;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;334;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;335;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;336;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;337;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;338;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;339;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;340;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;341;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;342;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;343;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;344;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;345;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;346;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;347;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;348;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;349;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;350;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;351;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;352;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;353;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;354;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;355;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;356;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;357;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;358;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;359;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;360;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;361;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;362;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;363;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;364;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;365;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;366;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;367;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;368;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;369;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;370;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;371;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;372;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;373;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;374;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;375;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;376;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;377;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;378;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;379;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;380;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;381;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;382;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;383;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;384;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;385;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;386;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;387;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;388;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;389;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;390;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;391;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;392;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;393;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;394;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;395;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;396;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;397;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;398;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;399;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;400;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;401;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;402;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;403;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;404;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;405;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;406;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;407;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;408;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;409;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;410;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;411;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;412;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;413;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;414;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;415;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;416;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;417;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;418;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;419;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;420;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;421;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;422;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;423;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;424;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;425;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;426;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;427;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;428;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;429;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;430;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;431;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;432;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;433;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;434;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;435;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;436;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;437;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;438;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;439;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;440;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;441;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;442;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;443;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;444;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;445;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;446;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;447;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;448;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;449;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;450;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;451;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;452;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;453;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;454;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;455;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;456;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;457;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;458;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;459;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;460;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;461;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;462;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;463;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;464;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;465;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;466;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;467;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;468;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;469;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;470;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;471;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;472;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;473;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;474;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;475;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;476;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;477;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;478;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;479;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;480;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;481;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;482;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;483;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;484;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;485;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;486;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;487;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;488;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;489;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;490;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;491;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;492;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;493;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;494;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;495;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;496;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;497;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;498;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;499;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;500;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;501;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;502;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;503;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;504;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;505;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;506;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;507;;
2;Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;508;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;1;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;2;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;3;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;4;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;5;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;6;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;7;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;8;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;9;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;10;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;11;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;12;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;13;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;14;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;15;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;16;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;17;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;18;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;19;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;20;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;21;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;22;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;23;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;24;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;25;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;26;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;27;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;28;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;29;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;30;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;31;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;32;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;33;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;34;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;35;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;36;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;37;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;38;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;39;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;40;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;41;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;42;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;43;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;44;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;45;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;46;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;47;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;48;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;49;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;50;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;51;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;52;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;53;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;54;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;55;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;56;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;57;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;58;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;59;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;60;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;61;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;62;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;63;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;64;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;65;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;66;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;67;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;68;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;69;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;70;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;71;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;72;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;73;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;74;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;75;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;76;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;77;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;78;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;79;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;80;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;81;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;82;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;83;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;84;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;85;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;86;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;87;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;88;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;89;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;90;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;91;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;92;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;93;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;94;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;95;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;96;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;97;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;98;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;99;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;100;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;101;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;102;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;103;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;104;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;105;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;106;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;107;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;108;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;109;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;110;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;111;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;112;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;113;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;114;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;115;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;116;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;117;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;118;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;119;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;120;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;121;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;122;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;123;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;124;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;125;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;126;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;127;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;128;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;129;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;130;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;131;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;132;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;133;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;134;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;135;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;136;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;137;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;138;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;139;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;140;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;141;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;142;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;143;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;144;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;145;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;146;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;147;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;148;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;149;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;150;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;151;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;152;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;153;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;154;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;155;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;156;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;157;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;158;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;159;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;160;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;161;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;162;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;163;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;164;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;165;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;166;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;167;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;168;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;169;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;170;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;171;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;172;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;173;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;174;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;175;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;176;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;177;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;178;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;179;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;180;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;181;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;182;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;183;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;184;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;185;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;186;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;187;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;188;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;189;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;190;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;191;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;192;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;193;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;194;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;195;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;196;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;197;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;198;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;199;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;200;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;201;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;202;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;203;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;204;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;205;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;206;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;207;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;208;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;209;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;210;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;211;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;212;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;213;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;214;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;215;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;216;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;217;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;218;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;219;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;220;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;221;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;222;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;223;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;224;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;225;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;226;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;227;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;228;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;229;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;230;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;231;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;232;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;233;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;234;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;235;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;236;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;237;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;238;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;239;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;240;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;241;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;242;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;243;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;244;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;245;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;246;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;247;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;248;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;249;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;250;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;251;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;252;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;253;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;254;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;255;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;256;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;257;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;258;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;259;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;260;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;261;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;262;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;263;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;264;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;265;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;266;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;267;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;268;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;269;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;270;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;271;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;272;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;273;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;274;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;275;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;276;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;277;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;278;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;279;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;280;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;281;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;282;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;283;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;284;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;285;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;286;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;287;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;288;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;289;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;290;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;291;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;292;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;293;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;294;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;295;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;296;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;297;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;298;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;299;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;300;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;301;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;302;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;303;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;304;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;305;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;306;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;307;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;308;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;309;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;310;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;311;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;312;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;313;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;314;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;315;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;316;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;317;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;318;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;319;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;320;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;321;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;322;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;323;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;324;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;325;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;326;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;327;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;328;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;329;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;330;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;331;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;332;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;333;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;334;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;335;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;336;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;337;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;338;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;339;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;340;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;341;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;342;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;343;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;344;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;345;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;346;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;347;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;348;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;349;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;350;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;351;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;352;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;353;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;354;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;355;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;356;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;357;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;358;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;359;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;360;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;361;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;362;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;363;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;364;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;365;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;366;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;367;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;368;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;369;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;370;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;371;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;372;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;373;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;374;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;375;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;376;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;377;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;378;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;379;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;380;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;381;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;382;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;383;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;384;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;385;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;386;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;387;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;388;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;389;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;390;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;391;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;392;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;393;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;394;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;395;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;396;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;397;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;398;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;399;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;400;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;401;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;402;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;403;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;404;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;405;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;406;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;407;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;408;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;409;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;410;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;411;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;412;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;413;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;414;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;415;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;416;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;417;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;418;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;419;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;420;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;421;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;422;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;423;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;424;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;425;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;426;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;427;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;428;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;429;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;430;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;431;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;432;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;433;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;434;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;435;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;436;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;437;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;438;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;439;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;440;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;441;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;442;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;443;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;444;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;445;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;446;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;447;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;448;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;449;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;450;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;451;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;452;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;453;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;454;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;455;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;456;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;457;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;458;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;459;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;460;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;461;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;462;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;463;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;464;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;465;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;466;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;467;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;468;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;469;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;470;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;471;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;472;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;473;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;474;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;475;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;476;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;477;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;478;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;479;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;480;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;481;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;482;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;483;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;484;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;485;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;486;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;487;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;488;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;489;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;490;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;491;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;492;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;493;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;494;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;495;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;496;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;497;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;498;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;499;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;500;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;501;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;502;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;503;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;504;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;505;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;506;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;507;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;508;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;509;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;510;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;511;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;512;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;513;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;514;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;515;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;516;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;517;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;518;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;519;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;520;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;521;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;522;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;523;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;524;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;525;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;526;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;527;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;528;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;529;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;530;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;531;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;532;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;533;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;534;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;535;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;536;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;537;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;538;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;539;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;540;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;541;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;542;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;543;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;544;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;545;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;546;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;547;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;548;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;549;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;550;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;551;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;552;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;553;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;554;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;555;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;556;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;557;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;558;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;559;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;560;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;561;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;562;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;563;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;564;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;565;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;566;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;567;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;568;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;569;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;570;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;571;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;572;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;573;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;574;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;575;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;576;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;577;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;578;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;579;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;580;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;581;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;582;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;583;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;584;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;585;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;586;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;587;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;588;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;589;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;590;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;591;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;592;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;593;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;594;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;595;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;596;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;597;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;598;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;599;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;600;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;601;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;602;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;603;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;604;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;605;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;606;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;607;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;608;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;609;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;610;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;611;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;612;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;613;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;614;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;615;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;16;616;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;617;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;618;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;619;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;620;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;621;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;622;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;623;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;624;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;625;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;626;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;627;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;628;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;629;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;630;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;631;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;632;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;633;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;634;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;635;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;636;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;637;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;638;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;639;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;640;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;641;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;642;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;643;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;644;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;645;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;646;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;647;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;648;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;649;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;650;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;651;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;652;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;653;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;654;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;655;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;656;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;657;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;658;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;659;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;17;660;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;661;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;662;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;663;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;664;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;665;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;666;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;667;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;668;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;669;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;670;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;671;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;672;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;673;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;674;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;675;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;676;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;677;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;678;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;679;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;680;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;681;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;682;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;683;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;684;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;685;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;686;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;687;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;688;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;689;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;690;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;691;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;692;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;693;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;694;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;695;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;696;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;697;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;698;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;699;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;700;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;701;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;702;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;703;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;704;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;18;705;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;706;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;707;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;708;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;709;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;710;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;711;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;712;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;713;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;714;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;715;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;716;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;717;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;718;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;719;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;720;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;721;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;722;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;723;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;724;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;725;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;726;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;727;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;728;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;729;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;730;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;731;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;732;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;733;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;734;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;735;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;736;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;737;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;738;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;739;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;740;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;741;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;742;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;743;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;744;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;745;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;746;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;747;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;748;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;19;749;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;750;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;751;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;752;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;753;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;754;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;755;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;756;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;757;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;758;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;759;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;760;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;761;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;762;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;763;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;764;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;765;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;766;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;767;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;768;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;769;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;770;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;771;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;772;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;773;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;774;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;775;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;776;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;777;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;778;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;779;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;780;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;781;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;782;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;783;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;784;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;785;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;786;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;787;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;788;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;789;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;790;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;791;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;792;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;793;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;794;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;795;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;796;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;20;797;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;798;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;799;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;800;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;801;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;802;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;803;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;804;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;805;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;806;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;807;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;808;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;809;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;810;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;811;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;812;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;813;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;814;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;815;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;816;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;817;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;818;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;819;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;820;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;821;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;822;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;823;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;824;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;825;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;826;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;827;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;828;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;829;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;830;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;831;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;832;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;833;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;834;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;835;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;836;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;837;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;838;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;839;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;840;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;21;841;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;842;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;843;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;844;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;845;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;846;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;847;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;848;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;849;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;850;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;851;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;852;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;853;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;854;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;855;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;856;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;857;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;858;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;859;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;860;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;861;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;862;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;863;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;864;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;865;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;866;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;867;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;868;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;869;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;870;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;871;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;872;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;873;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;874;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;875;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;876;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;877;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;878;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;879;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;880;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;22;881;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;882;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;883;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;884;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;885;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;886;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;887;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;888;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;889;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;890;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;891;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;892;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;893;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;894;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;895;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;896;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;897;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;898;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;899;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;900;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;901;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;902;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;903;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;904;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;905;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;906;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;907;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;908;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;909;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;910;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;911;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;912;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;913;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;914;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;915;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;916;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;917;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;918;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;919;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;920;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;921;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;922;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;923;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;924;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;925;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;926;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;927;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;928;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;929;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;930;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;23;931;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;932;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;933;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;934;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;935;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;936;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;937;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;938;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;939;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;940;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;941;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;942;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;943;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;944;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;945;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;946;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;947;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;948;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;949;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;950;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;951;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;952;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;953;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;954;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;955;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;956;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;957;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;958;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;959;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;960;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;961;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;962;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;963;;
3;Integrative analyses of TEDDY Omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;24;964;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;1;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;2;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;3;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;4;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;5;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;6;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;7;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;8;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;9;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;10;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;11;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;12;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;13;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;14;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;15;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;16;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;17;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;18;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;19;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;20;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;21;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;22;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;23;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;24;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;25;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;26;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;27;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;28;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;29;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;30;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;31;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;32;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;33;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;34;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;35;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;36;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;37;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;38;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;39;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;40;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;41;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;42;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;43;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;44;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;45;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;46;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;47;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;48;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;49;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;50;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;51;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;52;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;53;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;54;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;55;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;56;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;57;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;58;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;59;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;60;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;61;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;62;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;63;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;64;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;65;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;66;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;67;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;68;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;69;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;70;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;71;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;72;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;73;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;74;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;75;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;76;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;77;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;78;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;79;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;80;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;81;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;82;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;83;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;84;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;85;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;86;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;87;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;88;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;89;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;90;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;91;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;92;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;93;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;94;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;95;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;96;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;97;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;98;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;99;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;100;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;101;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;102;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;103;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;104;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;105;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;106;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;107;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;108;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;109;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;110;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;111;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;112;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;113;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;114;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;115;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;116;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;117;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;118;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;119;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;120;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;121;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;122;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;123;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;124;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;125;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;126;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;127;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;128;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;129;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;130;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;131;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;132;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;133;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;134;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;135;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;136;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;137;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;138;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;139;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;140;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;141;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;142;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;143;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;144;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;145;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;146;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;147;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;148;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;149;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;150;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;151;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;152;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;153;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;154;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;155;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;156;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;157;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;158;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;159;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;160;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;161;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;162;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;163;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;164;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;165;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;166;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;167;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;168;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;169;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;170;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;171;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;172;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;173;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;174;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;175;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;176;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;177;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;178;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;179;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;180;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;181;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;182;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;183;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;184;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;185;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;186;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;187;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;188;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;189;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;190;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;191;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;192;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;193;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;194;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;195;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;196;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;197;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;198;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;199;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;200;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;201;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;202;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;203;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;204;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;205;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;206;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;207;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;208;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;209;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;210;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;211;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;212;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;213;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;214;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;215;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;216;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;217;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;218;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;219;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;220;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;221;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;222;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;223;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;224;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;225;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;226;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;227;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;228;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;229;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;230;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;231;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;232;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;233;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;234;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;235;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;236;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;237;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;238;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;239;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;240;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;241;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;242;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;243;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;244;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;245;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;246;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;247;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;248;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;249;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;250;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;251;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;252;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;253;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;254;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;255;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;256;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;257;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;258;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;259;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;260;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;261;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;262;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;263;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;264;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;265;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;266;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;267;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;268;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;269;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;270;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;271;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;272;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;273;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;274;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;275;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;276;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;277;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;278;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;279;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;280;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;281;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;282;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;283;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;284;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;285;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;286;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;287;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;288;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;289;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;290;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;291;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;292;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;293;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;294;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;295;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;296;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;297;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;298;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;299;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;300;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;301;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;302;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;303;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;304;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;305;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;306;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;307;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;308;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;309;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;310;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;311;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;312;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;313;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;314;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;315;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;316;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;317;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;318;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;319;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;320;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;321;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;322;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;323;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;324;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;325;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;326;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;327;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;328;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;329;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;330;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;331;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;332;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;333;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;334;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;335;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;336;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;337;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;338;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;339;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;340;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;341;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;342;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;343;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;344;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;345;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;346;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;347;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;348;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;349;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;350;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;351;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;352;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;353;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;354;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;355;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;356;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;357;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;358;;
4;Integrative genomic analysis identified common regulatory networks underlying the correlation between coronary artery disease and plasma lipid levels.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;359;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;1;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;2;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;3;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;4;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;5;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;6;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;7;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;8;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;9;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;10;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;11;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;12;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;13;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;14;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;15;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;16;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;17;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;18;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;19;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;20;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;21;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;22;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;23;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;24;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;25;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;26;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;27;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;28;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;29;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;30;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;31;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;32;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;33;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;34;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;35;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;36;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;37;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;38;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;39;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;40;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;41;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;42;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;43;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;44;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;45;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;46;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;47;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;48;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;49;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;50;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;51;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;52;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;53;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;54;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;55;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;56;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;57;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;58;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;59;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;60;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;61;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;62;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;63;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;64;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;65;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;66;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;67;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;68;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;69;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;70;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;71;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;72;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;73;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;74;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;75;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;76;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;77;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;78;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;79;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;80;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;81;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;82;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;83;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;84;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;85;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;86;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;87;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;88;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;89;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;90;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;91;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;92;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;93;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;94;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;95;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;96;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;97;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;98;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;99;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;100;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;101;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;102;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;103;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;104;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;105;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;106;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;107;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;108;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;109;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;110;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;111;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;112;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;113;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;114;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;115;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;116;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;117;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;118;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;119;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;120;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;121;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;122;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;123;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;124;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;125;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;126;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;127;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;128;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;129;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;130;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;131;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;132;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;133;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;134;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;135;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;136;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;137;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;138;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;139;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;140;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;141;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;142;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;143;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;144;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;145;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;146;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;147;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;148;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;149;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;150;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;151;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;152;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;153;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;154;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;155;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;156;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;157;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;158;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;159;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;160;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;161;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;162;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;163;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;164;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;165;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;166;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;167;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;168;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;169;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;170;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;171;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;172;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;173;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;174;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;175;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;176;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;177;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;178;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;179;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;180;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;181;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;182;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;183;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;184;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;185;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;186;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;187;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;188;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;189;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;190;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;191;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;192;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;193;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;194;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;195;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;196;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;197;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;198;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;199;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;200;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;201;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;202;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;203;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;204;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;205;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;206;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;207;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;208;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;209;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;210;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;211;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;212;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;213;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;214;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;215;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;216;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;217;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;218;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;219;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;220;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;221;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;222;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;223;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;224;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;225;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;226;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;227;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;228;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;229;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;230;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;231;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;232;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;233;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;234;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;235;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;236;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;237;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;238;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;239;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;240;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;241;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;242;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;243;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;244;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;245;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;246;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;247;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;248;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;249;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;250;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;251;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;252;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;253;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;254;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;255;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;256;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;257;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;258;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;259;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;260;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;261;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;262;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;263;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;264;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;265;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;266;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;267;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;268;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;269;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;270;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;271;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;272;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;273;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;274;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;275;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;276;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;277;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;278;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;279;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;280;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;281;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;282;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;283;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;284;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;285;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;286;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;287;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;288;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;289;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;290;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;291;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;292;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;293;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;294;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;295;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;296;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;297;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;298;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;299;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;300;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;301;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;302;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;303;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;304;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;305;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;306;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;307;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;308;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;309;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;310;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;311;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;312;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;313;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;314;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;315;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;316;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;317;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;318;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;319;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;320;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;321;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;322;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;323;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;324;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;325;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;326;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;327;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;328;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;329;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;330;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;331;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;332;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;333;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;334;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;335;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;336;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;337;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;338;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;339;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;340;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;341;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;342;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;343;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;344;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;345;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;346;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;347;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;348;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;349;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;350;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;351;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;352;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;353;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;354;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;355;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;356;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;357;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;358;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;359;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;360;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;361;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;362;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;363;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;364;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;365;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;366;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;367;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;368;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;369;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;370;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;371;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;372;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;373;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;374;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;375;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;376;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;377;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;378;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;379;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;380;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;381;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;382;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;383;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;384;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;385;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;386;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;387;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;388;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;389;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;390;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;391;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;392;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;393;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;394;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;395;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;396;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;397;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;398;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;399;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;400;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;401;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;402;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;403;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;404;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;405;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;406;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;407;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;408;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;409;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;410;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;411;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;412;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;413;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;414;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;415;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;416;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;417;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;418;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;419;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;420;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;421;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;422;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;423;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;424;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;425;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;426;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;427;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;428;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;429;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;430;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;431;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;432;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;433;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;434;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;435;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;436;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;437;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;438;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;439;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;440;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;441;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;442;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;443;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;444;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;445;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;446;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;447;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;448;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;449;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;450;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;451;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;452;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;453;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;454;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;455;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;456;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;457;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;458;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;459;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;460;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;461;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;462;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;463;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;464;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;465;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;466;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;467;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;468;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;469;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;470;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;471;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;472;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;473;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;474;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;475;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;476;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;477;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;478;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;479;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;480;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;481;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;482;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;483;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;484;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;485;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;486;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;487;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;488;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;489;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;490;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;491;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;492;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;493;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;494;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;495;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;496;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;497;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;498;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;499;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;500;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;501;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;502;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;503;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;504;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;505;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;506;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;507;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;508;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;509;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;510;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;511;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;512;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;513;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;514;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;515;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;516;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;517;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;518;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;519;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;520;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;521;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;522;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;523;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;524;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;525;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;526;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;527;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;528;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;529;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;530;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;531;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;532;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;533;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;534;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;535;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;536;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;537;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;538;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;539;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;540;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;541;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;542;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;543;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;544;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;545;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;546;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;547;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;548;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;549;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;550;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;551;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;552;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;553;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;554;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;555;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;556;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;557;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;558;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;559;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;560;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;561;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;562;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;563;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;564;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;565;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;566;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;567;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;568;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;569;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;570;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;571;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;572;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;573;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;574;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;575;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;576;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;577;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;578;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;579;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;580;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;581;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;582;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;583;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;584;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;585;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;586;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;587;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;588;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;589;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;590;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;591;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;592;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;593;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;594;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;595;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;596;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;597;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;598;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;599;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;600;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;601;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;602;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;603;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;604;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;605;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;606;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;607;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;608;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;609;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;610;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;611;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;612;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;613;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;614;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;615;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;616;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;617;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;618;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;619;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;620;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;621;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;622;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;623;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;624;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;625;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;626;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;627;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;628;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;629;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;630;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;631;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;632;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;633;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;634;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;635;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;636;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;637;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;638;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;639;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;640;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;641;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;642;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;643;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;644;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;645;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;646;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;647;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;648;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;649;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;650;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;651;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;652;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;653;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;654;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;655;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;656;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;657;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;658;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;659;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;660;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;661;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;662;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;663;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;664;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;665;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;666;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;667;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;668;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;669;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;670;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;671;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;672;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;673;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;674;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;675;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;676;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;677;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;678;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;679;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;680;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;681;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;682;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;683;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;684;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;685;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;686;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;687;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;688;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;689;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;690;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;691;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;692;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;693;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;694;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;695;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;696;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;697;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;698;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;699;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;700;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;701;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;702;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;703;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;704;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;705;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;706;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;707;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;708;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;709;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;710;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;711;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;712;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;713;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;714;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;715;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;716;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;717;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;718;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;719;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;720;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;721;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;722;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;723;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;724;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;725;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;726;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;727;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;728;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;729;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;730;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;731;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;732;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;733;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;734;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;735;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;736;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;737;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;738;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;739;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;740;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;741;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;742;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;743;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;744;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;745;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;746;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;747;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;748;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;749;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;750;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;751;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;752;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;753;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;754;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;755;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;756;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;757;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;758;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;759;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;760;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;761;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;762;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;763;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;764;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;765;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;766;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;767;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;768;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;769;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;770;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;771;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;772;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;773;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;774;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;775;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;776;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;777;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;778;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;779;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;780;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;781;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;782;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;783;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;784;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;785;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;786;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;787;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;788;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;789;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;790;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;791;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;792;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;793;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;794;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;795;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;796;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;797;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;798;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;799;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;800;;
5;JDSNMF- Joint Deep Semi-Non-Negative Matrix Factorization for Learning Integrative Representation of Molecular Signals in Alzheimer's Disease.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;801;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;1;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;2;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;3;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;4;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;5;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;6;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;7;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;8;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;9;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;10;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;11;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;12;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;13;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;14;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;15;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;16;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;17;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;18;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;19;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;20;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;21;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;22;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;23;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;24;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;25;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;26;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;27;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;28;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;29;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;30;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;31;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;32;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;33;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;34;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;35;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;36;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;37;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;38;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;39;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;40;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;41;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;42;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;43;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;44;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;45;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;46;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;47;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;48;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;49;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;50;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;51;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;52;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;53;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;54;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;55;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;56;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;57;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;58;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;59;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;60;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;61;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;62;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;63;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;64;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;65;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;66;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;67;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;68;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;69;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;70;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;71;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;72;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;73;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;74;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;75;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;76;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;77;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;78;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;79;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;80;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;81;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;82;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;83;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;84;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;85;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;86;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;87;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;88;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;89;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;90;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;91;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;92;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;93;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;94;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;95;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;96;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;97;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;98;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;99;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;100;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;101;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;102;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;103;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;104;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;105;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;106;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;107;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;108;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;109;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;110;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;111;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;112;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;113;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;114;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;115;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;116;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;117;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;118;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;119;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;120;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;121;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;122;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;123;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;124;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;125;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;126;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;127;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;128;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;129;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;130;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;131;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;132;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;133;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;134;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;135;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;136;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;137;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;138;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;139;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;140;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;141;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;142;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;143;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;144;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;145;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;146;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;147;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;148;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;149;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;150;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;151;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;152;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;153;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;154;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;155;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;156;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;157;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;158;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;159;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;160;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;161;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;162;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;163;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;164;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;165;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;166;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;167;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;168;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;169;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;170;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;171;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;172;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;173;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;174;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;175;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;176;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;177;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;178;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;179;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;180;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;181;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;182;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;183;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;184;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;185;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;186;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;187;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;188;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;189;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;190;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;191;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;192;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;193;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;194;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;195;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;196;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;197;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;198;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;199;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;200;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;201;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;202;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;203;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;204;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;205;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;206;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;207;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;208;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;209;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;210;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;211;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;212;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;213;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;214;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;215;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;216;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;217;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;218;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;219;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;220;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;221;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;222;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;223;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;224;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;225;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;226;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;227;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;228;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;229;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;230;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;231;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;232;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;233;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;234;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;235;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;236;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;237;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;238;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;239;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;240;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;241;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;242;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;243;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;244;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;245;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;246;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;247;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;248;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;249;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;250;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;251;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;252;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;253;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;254;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;255;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;256;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;257;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;258;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;259;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;260;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;261;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;262;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;263;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;264;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;265;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;266;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;267;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;268;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;269;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;270;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;271;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;272;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;273;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;274;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;275;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;276;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;277;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;278;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;279;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;280;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;281;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;282;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;283;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;284;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;285;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;286;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;287;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;288;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;289;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;290;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;291;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;292;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;293;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;294;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;295;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;296;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;297;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;298;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;299;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;300;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;301;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;302;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;303;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;304;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;305;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;306;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;307;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;308;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;309;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;310;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;311;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;312;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;313;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;314;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;315;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;316;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;317;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;318;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;319;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;320;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;321;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;322;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;323;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;324;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;325;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;326;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;327;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;328;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;329;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;330;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;331;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;332;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;333;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;334;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;335;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;336;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;337;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;338;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;339;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;340;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;341;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;342;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;343;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;344;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;345;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;346;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;347;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;348;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;349;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;350;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;351;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;352;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;353;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;354;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;355;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;356;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;357;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;358;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;359;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;360;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;361;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;362;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;363;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;364;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;365;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;366;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;367;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;368;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;369;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;370;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;371;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;372;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;373;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;374;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;375;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;376;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;377;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;378;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;379;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;380;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;381;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;382;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;383;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;384;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;385;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;386;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;387;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;388;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;389;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;390;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;391;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;392;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;393;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;394;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;395;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;396;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;397;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;398;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;399;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;400;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;401;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;402;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;403;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;404;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;405;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;406;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;407;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;408;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;409;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;410;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;411;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;412;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;413;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;414;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;415;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;416;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;417;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;418;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;419;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;420;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;421;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;422;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;423;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;424;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;425;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;426;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;427;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;428;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;429;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;430;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;431;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;432;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;433;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;434;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;435;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;436;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;437;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;438;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;439;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;440;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;441;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;442;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;443;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;444;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;445;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;446;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;447;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;448;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;449;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;450;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;451;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;452;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;453;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;454;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;455;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;456;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;457;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;458;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;459;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;460;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;461;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;462;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;463;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;464;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;465;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;466;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;467;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;468;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;469;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;470;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;471;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;472;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;473;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;474;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;475;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;476;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;477;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;478;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;479;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;480;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;481;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;482;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;483;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;484;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;485;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;486;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;487;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;488;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;489;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;490;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;491;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;492;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;493;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;494;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;495;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;496;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;497;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;498;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;499;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;500;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;501;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;502;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;503;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;504;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;505;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;506;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;507;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;508;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;509;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;510;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;511;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;512;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;513;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;514;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;515;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;516;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;517;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;518;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;519;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;520;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;521;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;522;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;523;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;524;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;525;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;526;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;527;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;528;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;529;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;530;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;531;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;532;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;533;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;534;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;535;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;536;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;537;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;538;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;539;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;540;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;541;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;542;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;543;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;544;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;545;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;546;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;547;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;548;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;549;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;550;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;551;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;552;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;553;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;554;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;555;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;556;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;557;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;558;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;559;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;560;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;561;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;562;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;563;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;564;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;565;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;566;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;567;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;568;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;569;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;570;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;571;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;572;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;573;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;574;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;575;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;576;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;577;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;578;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;579;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;580;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;581;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;582;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;583;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;584;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;585;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;586;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;587;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;588;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;589;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;590;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;591;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;592;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;593;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;594;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;595;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;596;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;597;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;598;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;599;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;600;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;601;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;602;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;603;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;604;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;605;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;606;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;607;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;608;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;609;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;610;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;611;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;612;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;613;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;614;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;615;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;616;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;617;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;618;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;619;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;620;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;621;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;622;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;623;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;624;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;625;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;626;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;627;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;628;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;629;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;630;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;631;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;632;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;633;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;634;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;635;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;636;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;637;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;638;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;639;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;640;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;641;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;642;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;643;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;644;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;645;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;646;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;647;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;648;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;649;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;650;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;651;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;652;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;653;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;654;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;655;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;656;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;657;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;658;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;659;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;660;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;661;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;662;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;663;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;664;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;665;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;666;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;667;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;668;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;669;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;670;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;671;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;672;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;673;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;674;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;675;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;676;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;677;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;678;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;679;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;680;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;681;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;682;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;683;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;684;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;685;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;686;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;687;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;688;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;689;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;690;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;691;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;692;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;693;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;694;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;695;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;696;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;697;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;698;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;699;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;700;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;701;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;702;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;703;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;704;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;705;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;706;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;707;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;708;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;709;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;710;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;711;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;712;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;713;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;714;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;715;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;716;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;717;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;718;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;719;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;720;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;721;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;722;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;723;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;724;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;725;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;726;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;727;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;728;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;729;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;730;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;731;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;732;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;733;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;734;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;735;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;736;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;737;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;738;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;739;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;740;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;741;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;742;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;743;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;744;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;745;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;746;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;747;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;748;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;749;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;750;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;751;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;752;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;753;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;754;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;755;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;756;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;757;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;758;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;759;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;760;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;761;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;762;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;763;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;764;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;765;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;766;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;767;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;768;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;769;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;770;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;771;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;772;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;773;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;774;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;775;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;776;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;777;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;778;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;779;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;780;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;781;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;782;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;783;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;784;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;785;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;786;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;787;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;788;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;789;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;790;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;791;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;792;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;793;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;794;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;795;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;796;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;797;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;798;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;799;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;800;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;801;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;802;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;803;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;804;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;805;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;806;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;807;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;808;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;809;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;810;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;811;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;812;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;813;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;814;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;815;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;816;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;817;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;818;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;819;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;820;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;821;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;822;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;823;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;824;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;825;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;826;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;827;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;828;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;829;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;830;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;831;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;832;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;833;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;834;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;835;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;836;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;837;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;838;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;839;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;840;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;841;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;842;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;843;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;844;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;845;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;846;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;847;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;848;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;849;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;850;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;851;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;852;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;853;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;854;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;855;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;856;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;857;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;858;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;859;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;860;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;861;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;862;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;863;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;864;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;865;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;866;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;867;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;868;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;869;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;870;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;871;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;872;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;873;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;874;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;875;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;876;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;877;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;878;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;879;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;880;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;881;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;882;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;883;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;884;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;885;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;886;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;887;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;888;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;889;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;890;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;891;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;892;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;893;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;894;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;895;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;896;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;897;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;898;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;899;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;900;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;901;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;902;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;903;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;904;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;905;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;906;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;907;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;908;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;909;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;910;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;911;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;912;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;913;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;914;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;915;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;916;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;917;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;918;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;919;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;920;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;921;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;922;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;923;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;924;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;925;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;926;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;927;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;928;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;929;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;930;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;931;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;932;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;933;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;934;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;935;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;936;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;937;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;938;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;939;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;940;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;941;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;942;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;943;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;944;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;945;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;946;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;947;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;948;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;949;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;950;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;951;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;952;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;953;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;954;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;955;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;956;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;957;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;958;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;959;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;960;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;961;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;962;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;963;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;964;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;965;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;966;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;967;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;968;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;969;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;970;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;971;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;972;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;973;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;974;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;975;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;976;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;977;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;978;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;979;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;980;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;981;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;982;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;983;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;984;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;985;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;986;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;987;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;988;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;989;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;990;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;991;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;992;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;993;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;994;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;995;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;996;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;997;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;998;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;999;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1000;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1001;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1002;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1003;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1004;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1005;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1006;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1007;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1008;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1009;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1010;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1011;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1012;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1013;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1014;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1015;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1016;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1017;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1018;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1019;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1020;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1021;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1022;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1023;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1024;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1025;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1026;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1027;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1028;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1029;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1030;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1031;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1032;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1033;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1034;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1035;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1036;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1037;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1038;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1039;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1040;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1041;;
7;Multi‑omic analyses in Abyssinian cats with primary renal amyloid deposits.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;1042;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;1;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;2;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;3;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;4;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;5;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;6;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;7;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;8;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;9;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;10;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;11;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;12;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;13;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;14;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;15;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;16;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;17;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;18;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;19;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;20;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;21;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;22;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;23;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;24;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;25;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;26;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;27;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;28;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;29;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;30;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;31;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;32;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;33;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;34;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;35;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;36;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;37;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;38;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;39;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;40;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;41;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;42;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;43;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;44;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;45;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;46;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;47;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;48;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;49;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;50;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;51;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;52;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;53;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;54;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;55;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;56;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;57;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;58;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;59;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;60;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;61;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;62;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;63;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;64;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;65;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;66;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;67;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;68;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;69;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;70;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;71;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;72;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;73;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;74;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;75;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;76;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;77;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;78;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;79;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;80;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;81;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;82;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;83;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;84;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;85;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;86;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;87;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;88;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;89;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;90;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;91;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;92;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;93;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;94;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;95;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;96;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;97;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;98;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;99;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;100;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;101;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;102;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;103;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;104;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;105;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;106;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;107;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;108;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;109;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;110;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;111;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;112;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;113;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;114;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;115;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;116;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;117;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;118;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;119;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;120;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;121;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;122;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;123;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;124;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;125;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;126;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;127;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;128;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;129;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;130;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;131;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;132;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;133;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;134;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;135;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;136;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;137;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;138;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;139;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;140;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;141;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;142;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;143;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;144;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;145;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;146;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;147;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;148;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;149;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;150;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;151;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;152;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;153;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;154;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;155;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;156;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;157;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;158;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;159;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;160;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;161;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;162;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;163;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;164;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;165;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;166;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;167;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;168;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;169;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;170;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;171;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;172;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;173;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;174;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;175;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;176;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;177;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;178;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;179;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;180;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;181;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;182;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;183;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;184;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;185;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;186;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;187;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;188;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;189;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;190;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;191;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;192;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;193;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;194;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;195;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;196;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;197;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;198;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;199;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;200;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;201;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;202;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;203;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;204;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;205;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;206;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;207;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;208;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;209;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;210;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;211;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;212;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;213;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;214;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;215;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;216;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;217;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;218;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;219;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;220;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;221;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;222;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;223;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;224;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;225;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;226;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;227;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;228;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;229;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;230;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;231;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;232;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;233;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;234;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;235;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;236;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;237;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;238;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;239;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;240;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;241;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;242;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;243;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;244;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;245;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;246;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;247;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;248;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;249;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;250;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;251;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;252;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;253;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;254;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;255;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;256;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;257;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;258;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;259;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;260;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;261;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;262;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;263;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;264;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;265;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;266;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;267;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;268;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;269;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;270;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;271;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;272;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;273;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;274;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;275;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;276;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;277;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;278;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;279;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;280;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;281;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;282;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;283;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;284;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;285;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;286;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;287;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;288;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;289;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;290;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;291;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;292;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;293;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;294;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;295;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;296;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;297;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;298;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;299;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;300;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;301;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;302;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;303;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;304;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;305;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;306;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;307;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;308;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;309;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;310;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;311;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;312;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;313;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;314;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;315;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;316;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;317;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;318;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;319;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;320;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;321;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;322;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;323;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;324;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;325;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;326;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;327;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;328;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;329;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;330;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;331;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;332;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;333;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;334;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;335;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;336;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;337;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;338;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;339;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;340;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;341;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;342;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;343;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;344;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;345;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;346;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;347;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;348;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;349;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;350;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;351;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;352;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;353;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;354;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;355;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;356;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;357;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;358;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;359;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;360;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;361;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;362;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;363;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;364;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;365;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;366;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;367;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;368;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;369;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;370;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;371;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;372;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;373;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;374;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;375;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;376;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;377;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;378;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;379;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;380;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;381;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;382;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;383;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;384;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;385;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;386;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;387;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;388;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;389;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;390;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;391;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;392;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;393;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;394;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;395;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;396;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;397;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;398;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;399;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;400;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;401;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;402;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;403;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;404;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;405;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;406;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;407;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;408;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;409;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;410;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;411;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;412;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;413;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;414;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;415;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;416;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;417;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;418;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;419;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;420;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;421;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;422;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;423;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;424;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;425;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;426;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;427;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;428;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;429;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;430;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;431;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;432;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;433;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;434;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;435;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;436;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;437;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;438;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;439;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;440;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;441;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;442;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;443;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;444;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;445;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;446;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;447;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;448;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;449;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;450;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;451;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;452;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;453;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;454;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;455;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;456;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;457;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;458;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;459;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;460;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;461;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;462;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;463;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;464;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;465;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;466;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;467;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;468;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;469;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;470;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;471;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;472;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;473;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;474;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;475;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;476;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;477;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;478;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;479;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;480;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;481;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;482;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;483;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;484;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;485;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;486;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;487;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;488;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;489;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;490;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;491;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;492;;
8;Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;493;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;1;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;2;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;3;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;4;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;5;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;6;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;7;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;8;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;9;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;10;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;11;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;12;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;13;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;14;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;15;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;16;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;17;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;18;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;19;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;20;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;21;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;22;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;23;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;24;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;25;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;26;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;27;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;28;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;29;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;30;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;31;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;32;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;33;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;34;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;35;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;36;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;37;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;38;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;39;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;40;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;41;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;42;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;43;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;44;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;45;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;46;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;47;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;48;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;49;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;50;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;51;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;52;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;53;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;54;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;55;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;56;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;57;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;58;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;59;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;60;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;61;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;62;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;63;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;64;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;65;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;66;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;67;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;68;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;69;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;70;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;71;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;72;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;73;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;74;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;75;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;76;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;77;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;78;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;79;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;80;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;81;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;82;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;83;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;84;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;85;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;86;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;87;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;88;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;89;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;90;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;91;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;92;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;93;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;94;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;95;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;96;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;97;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;98;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;99;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;100;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;101;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;102;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;103;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;104;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;105;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;106;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;107;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;108;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;109;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;110;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;111;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;112;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;113;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;114;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;115;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;116;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;117;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;118;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;119;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;120;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;121;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;122;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;123;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;124;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;125;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;126;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;127;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;128;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;129;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;130;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;131;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;132;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;133;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;134;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;135;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;136;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;137;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;138;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;139;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;140;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;141;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;142;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;143;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;144;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;145;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;146;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;147;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;148;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;149;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;150;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;151;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;152;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;153;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;154;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;155;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;156;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;157;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;158;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;159;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;160;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;161;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;162;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;163;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;164;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;165;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;166;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;167;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;168;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;169;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;170;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;171;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;172;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;173;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;174;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;175;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;176;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;177;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;178;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;179;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;180;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;181;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;182;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;183;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;184;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;185;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;186;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;187;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;188;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;189;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;190;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;191;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;192;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;193;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;194;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;195;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;196;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;197;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;198;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;199;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;200;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;201;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;202;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;203;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;204;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;205;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;206;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;207;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;208;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;209;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;210;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;211;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;212;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;213;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;214;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;215;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;216;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;217;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;218;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;219;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;220;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;221;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;222;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;223;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;224;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;225;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;226;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;227;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;228;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;229;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;230;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;231;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;232;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;233;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;234;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;235;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;236;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;237;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;238;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;239;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;240;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;241;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;242;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;243;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;244;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;245;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;246;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;247;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;248;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;249;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;250;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;251;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;252;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;253;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;254;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;255;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;256;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;257;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;258;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;259;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;260;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;261;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;262;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;263;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;264;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;265;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;266;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;267;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;268;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;269;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;270;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;271;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;272;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;273;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;274;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;275;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;276;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;277;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;278;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;279;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;280;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;281;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;282;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;283;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;284;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;285;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;286;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;287;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;288;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;289;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;290;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;291;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;292;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;293;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;294;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;295;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;296;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;297;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;298;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;299;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;300;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;301;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;302;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;303;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;304;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;305;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;306;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;307;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;308;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;309;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;310;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;311;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;312;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;313;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;314;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;315;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;316;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;317;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;318;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;319;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;320;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;321;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;322;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;323;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;324;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;325;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;326;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;327;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;328;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;329;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;330;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;331;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;332;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;333;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;334;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;335;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;336;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;337;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;338;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;339;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;340;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;341;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;342;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;343;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;344;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;345;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;346;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;347;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;348;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;349;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;350;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;351;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;352;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;353;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;354;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;355;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;356;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;357;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;358;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;359;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;360;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;361;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;362;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;363;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;364;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;365;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;366;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;367;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;368;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;369;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;370;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;371;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;372;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;373;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;374;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;375;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;376;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;377;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;378;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;379;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;380;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;381;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;382;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;383;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;384;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;385;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;386;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;387;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;388;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;389;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;390;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;391;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;392;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;393;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;394;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;395;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;396;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;397;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;398;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;399;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;400;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;401;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;402;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;403;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;404;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;405;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;406;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;407;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;408;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;409;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;410;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;411;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;412;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;413;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;414;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;415;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;416;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;417;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;418;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;419;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;420;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;421;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;422;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;423;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;424;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;425;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;426;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;427;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;428;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;429;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;430;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;431;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;432;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;433;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;434;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;435;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;436;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;437;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;438;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;439;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;440;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;441;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;442;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;443;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;444;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;445;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;446;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;447;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;448;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;449;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;450;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;451;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;452;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;453;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;454;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;455;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;456;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;457;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;458;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;459;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;460;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;461;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;462;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;463;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;464;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;465;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;466;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;467;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;468;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;469;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;470;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;471;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;472;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;473;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;474;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;475;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;476;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;477;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;478;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;479;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;480;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;481;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;482;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;483;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;484;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;485;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;486;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;487;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;488;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;489;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;490;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;491;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;492;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;493;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;494;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;495;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;496;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;497;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;498;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;499;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;500;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;501;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;502;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;503;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;504;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;505;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;506;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;507;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;508;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;509;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;510;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;511;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;512;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;513;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;514;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;515;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;516;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;517;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;518;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;519;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;520;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;521;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;522;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;523;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;524;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;525;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;526;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;527;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;528;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;529;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;530;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;531;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;532;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;533;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;534;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;535;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;536;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;537;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;538;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;539;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;540;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;541;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;542;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;543;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;544;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;545;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;546;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;547;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;548;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;549;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;550;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;551;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;552;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;553;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;554;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;555;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;556;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;557;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;558;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;559;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;560;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;561;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;562;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;563;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;564;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;565;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;566;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;567;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;568;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;569;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;570;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;571;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;572;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;573;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;574;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;575;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;576;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;577;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;578;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;579;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;580;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;581;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;582;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;583;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;584;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;585;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;586;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;587;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;588;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;589;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;590;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;591;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;592;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;593;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;594;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;595;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;596;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;597;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;598;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;599;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;600;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;601;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;602;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;603;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;604;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;605;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;606;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;607;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;608;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;609;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;610;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;611;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;612;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;613;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;614;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;615;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;616;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;617;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;618;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;619;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;620;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;621;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;622;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;623;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;624;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;625;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;626;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;627;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;628;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;629;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;630;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;631;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;632;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;633;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;634;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;635;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;636;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;637;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;638;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;639;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;640;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;641;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;642;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;643;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;644;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;645;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;646;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;647;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;648;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;649;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;650;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;651;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;652;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;653;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;654;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;655;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;656;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;657;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;658;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;659;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;660;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;661;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;662;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;663;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;664;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;665;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;666;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;667;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;668;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;669;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;670;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;671;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;672;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;673;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;674;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;675;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;676;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;677;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;678;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;679;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;680;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;681;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;682;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;683;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;684;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;685;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;686;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;687;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;688;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;689;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;690;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;691;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;692;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;693;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;694;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;695;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;696;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;697;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;698;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;699;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;700;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;701;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;702;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;703;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;704;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;705;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;706;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;707;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;708;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;709;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;710;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;711;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;712;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;713;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;714;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;715;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;716;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;717;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;718;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;719;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;720;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;721;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;722;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;723;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;724;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;725;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;726;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;727;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;728;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;729;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;730;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;731;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;732;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;733;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;734;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;735;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;736;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;737;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;738;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;739;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;740;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;741;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;742;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;743;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;744;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;745;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;746;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;747;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;748;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;749;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;750;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;751;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;752;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;753;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;754;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;755;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;756;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;757;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;758;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;759;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;760;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;761;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;762;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;763;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;764;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;765;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;766;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;767;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;768;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;769;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;770;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;771;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;772;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;773;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;774;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;775;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;776;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;777;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;778;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;779;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;780;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;781;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;782;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;783;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;784;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;785;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;786;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;787;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;788;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;789;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;790;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;791;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;792;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;793;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;794;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;795;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;796;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;797;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;798;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;799;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;800;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;801;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;802;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;803;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;804;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;805;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;806;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;807;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;808;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;809;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;810;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;811;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;812;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;813;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;814;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;815;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;816;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;817;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;818;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;819;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;820;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;821;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;822;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;823;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;824;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;825;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;826;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;827;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;828;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;829;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;830;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;831;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;832;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;833;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;834;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;835;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;836;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;837;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;838;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;839;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;840;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;841;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;842;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;843;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;844;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;845;;
9;NREM delta power and AD‑relevant tauopathy are associated with shared cortical gene networks.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;846;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;1;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;2;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;3;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;4;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;5;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;6;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;7;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;8;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;9;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;10;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;11;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;12;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;13;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;14;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;15;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;16;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;17;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;18;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;19;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;20;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;21;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;22;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;23;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;24;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;25;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;26;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;27;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;28;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;29;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;30;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;31;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;32;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;33;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;34;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;35;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;36;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;37;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;38;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;39;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;40;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;41;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;42;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;43;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;44;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;45;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;46;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;47;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;48;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;49;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;50;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;51;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;52;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;53;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;54;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;55;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;56;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;57;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;58;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;59;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;60;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;61;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;62;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;63;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;64;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;65;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;66;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;67;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;68;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;69;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;70;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;71;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;72;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;73;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;74;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;75;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;76;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;77;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;78;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;79;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;80;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;81;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;82;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;83;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;84;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;85;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;86;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;87;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;88;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;89;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;90;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;91;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;92;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;93;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;94;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;95;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;96;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;97;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;98;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;99;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;100;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;101;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;102;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;103;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;104;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;105;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;106;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;107;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;108;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;109;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;110;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;111;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;112;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;113;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;114;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;115;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;116;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;117;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;118;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;119;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;120;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;121;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;122;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;123;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;124;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;125;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;126;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;127;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;128;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;129;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;130;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;131;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;132;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;133;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;134;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;135;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;136;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;137;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;138;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;139;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;140;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;141;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;142;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;143;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;144;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;145;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;146;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;147;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;148;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;149;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;150;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;151;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;152;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;153;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;154;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;155;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;156;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;157;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;158;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;159;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;160;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;161;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;162;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;163;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;164;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;165;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;166;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;167;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;168;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;169;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;170;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;171;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;172;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;173;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;174;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;175;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;176;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;177;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;178;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;179;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;180;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;181;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;182;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;183;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;184;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;185;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;186;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;187;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;188;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;189;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;190;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;191;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;192;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;193;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;194;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;195;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;196;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;197;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;198;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;199;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;200;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;201;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;202;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;203;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;204;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;205;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;206;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;207;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;208;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;209;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;210;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;211;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;212;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;213;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;214;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;215;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;216;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;217;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;218;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;219;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;220;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;221;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;222;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;223;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;224;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;225;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;226;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;227;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;228;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;229;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;230;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;231;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;232;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;233;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;234;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;235;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;236;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;237;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;238;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;239;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;240;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;241;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;242;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;243;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;244;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;245;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;246;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;247;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;248;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;249;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;250;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;251;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;252;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;253;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;254;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;255;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;256;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;257;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;258;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;259;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;260;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;261;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;262;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;263;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;264;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;265;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;266;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;267;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;268;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;269;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;270;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;271;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;272;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;273;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;274;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;275;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;276;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;277;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;278;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;279;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;280;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;281;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;282;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;283;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;284;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;285;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;286;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;287;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;288;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;289;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;290;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;291;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;292;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;293;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;294;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;295;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;296;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;297;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;298;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;299;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;300;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;301;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;302;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;303;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;304;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;305;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;306;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;307;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;308;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;309;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;310;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;311;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;312;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;313;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;314;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;315;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;316;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;317;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;318;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;319;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;320;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;321;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;322;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;323;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;324;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;325;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;326;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;327;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;328;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;329;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;330;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;331;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;332;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;333;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;334;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;335;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;336;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;337;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;338;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;339;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;340;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;341;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;342;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;343;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;344;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;345;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;346;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;347;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;348;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;349;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;350;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;351;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;352;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;353;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;354;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;355;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;356;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;357;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;8;358;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;359;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;360;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;361;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;362;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;363;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;364;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;365;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;366;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;367;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;368;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;369;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;370;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;371;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;372;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;373;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;374;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;375;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;376;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;377;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;378;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;379;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;380;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;381;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;382;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;383;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;384;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;385;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;386;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;387;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;388;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;389;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;390;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;391;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;392;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;393;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;394;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;395;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;396;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;397;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;398;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;399;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;400;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;401;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;402;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;403;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;404;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;405;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;406;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;407;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;408;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;409;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;410;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;9;411;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;412;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;413;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;414;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;415;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;416;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;417;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;418;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;419;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;420;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;421;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;422;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;423;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;424;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;425;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;426;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;427;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;428;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;429;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;430;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;431;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;432;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;433;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;434;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;435;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;436;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;437;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;438;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;439;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;440;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;441;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;442;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;443;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;444;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;445;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;446;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;447;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;448;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;449;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;450;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;451;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;452;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;453;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;454;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;455;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;456;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;457;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;458;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;459;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;460;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;461;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;462;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;463;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;464;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;465;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;10;466;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;467;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;468;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;469;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;470;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;471;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;472;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;473;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;474;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;475;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;476;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;477;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;478;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;479;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;480;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;481;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;482;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;483;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;484;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;485;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;486;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;487;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;488;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;489;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;490;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;491;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;492;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;493;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;494;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;495;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;496;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;497;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;498;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;499;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;500;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;501;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;502;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;503;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;504;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;505;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;506;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;507;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;508;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;509;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;510;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;511;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;512;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;513;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;514;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;515;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;516;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;517;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;518;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;519;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;520;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;11;521;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;522;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;523;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;524;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;525;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;526;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;527;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;528;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;529;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;530;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;531;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;532;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;533;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;534;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;535;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;536;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;537;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;538;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;539;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;540;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;541;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;542;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;543;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;544;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;545;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;546;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;547;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;548;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;549;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;550;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;551;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;552;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;553;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;554;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;555;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;556;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;557;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;558;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;559;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;560;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;561;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;562;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;563;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;564;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;565;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;566;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;567;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;568;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;569;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;570;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;571;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;572;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;573;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;574;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;575;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;576;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;577;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;578;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;579;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;580;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;581;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;582;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;583;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;584;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;585;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;586;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;587;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;588;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;589;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;590;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;591;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;592;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;593;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;594;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;12;595;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;596;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;597;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;598;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;599;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;600;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;601;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;602;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;603;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;604;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;605;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;606;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;607;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;608;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;609;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;610;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;611;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;612;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;613;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;614;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;615;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;616;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;617;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;618;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;619;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;620;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;621;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;622;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;623;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;624;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;625;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;626;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;627;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;628;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;629;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;630;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;631;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;632;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;633;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;634;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;635;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;636;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;637;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;638;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;639;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;640;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;641;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;642;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;643;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;644;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;645;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;646;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;647;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;648;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;649;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;650;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;651;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;652;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;653;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;654;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;655;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;656;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;657;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;658;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;659;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;660;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;661;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;662;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;663;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;664;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;665;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;666;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;13;667;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;668;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;669;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;670;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;671;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;672;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;673;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;674;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;675;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;676;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;677;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;678;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;679;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;680;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;681;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;682;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;683;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;684;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;685;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;686;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;687;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;688;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;689;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;690;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;691;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;692;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;693;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;694;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;695;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;696;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;697;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;698;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;699;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;700;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;701;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;702;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;703;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;704;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;705;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;706;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;707;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;708;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;709;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;710;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;711;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;712;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;713;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;714;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;715;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;716;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;717;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;718;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;719;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;720;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;721;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;722;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;723;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;724;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;725;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;726;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;727;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;728;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;729;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;730;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;731;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;732;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;733;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;734;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;735;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;736;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;737;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;738;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;14;739;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;740;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;741;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;742;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;743;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;744;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;745;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;746;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;747;;
10;RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;15;748;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;1;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;2;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;3;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;4;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;5;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;6;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;7;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;8;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;9;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;10;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;11;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;12;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;13;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;14;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;15;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;16;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;17;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;18;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;19;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;20;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;21;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;22;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;23;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;24;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;25;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;26;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;27;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;28;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;29;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;30;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;31;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;32;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;33;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;34;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;35;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;36;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;37;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;38;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;39;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;40;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;41;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;42;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;43;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;44;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;45;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;46;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;47;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;48;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;49;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;50;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;51;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;52;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;53;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;54;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;55;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;56;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;57;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;58;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;59;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;60;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;61;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;62;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;63;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;64;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;65;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;66;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;67;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;68;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;69;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;70;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;71;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;72;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;73;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;74;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;75;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;76;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;77;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;78;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;79;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;80;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;81;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;82;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;83;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;84;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;85;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;86;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;87;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;88;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;89;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;90;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;91;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;92;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;93;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;94;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;95;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;96;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;97;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;98;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;99;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;100;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;101;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;102;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;103;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;104;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;105;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;106;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;107;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;108;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;109;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;110;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;111;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;112;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;113;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;114;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;115;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;116;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;117;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;118;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;119;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;120;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;121;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;122;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;123;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;124;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;125;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;126;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;127;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;128;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;129;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;130;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;131;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;132;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;133;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;134;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;135;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;136;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;137;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;138;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;139;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;140;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;141;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;142;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;143;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;144;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;145;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;146;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;147;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;148;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;149;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;150;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;151;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;152;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;153;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;154;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;155;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;156;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;157;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;158;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;159;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;160;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;161;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;162;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;163;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;164;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;165;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;166;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;167;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;168;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;169;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;170;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;171;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;172;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;173;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;174;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;175;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;176;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;177;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;178;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;179;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;180;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;181;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;182;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;183;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;184;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;185;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;186;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;187;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;188;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;189;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;190;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;191;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;192;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;193;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;194;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;195;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;196;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;197;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;198;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;199;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;200;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;201;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;202;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;203;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;204;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;205;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;206;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;207;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;208;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;209;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;210;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;211;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;212;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;213;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;214;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;215;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;216;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;217;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;218;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;219;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;220;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;221;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;222;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;223;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;224;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;225;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;226;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;227;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;228;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;229;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;230;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;231;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;232;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;233;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;234;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;235;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;236;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;237;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;238;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;239;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;240;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;241;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;242;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;243;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;244;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;245;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;246;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;247;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;248;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;249;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;250;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;251;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;252;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;253;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;254;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;255;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;256;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;257;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;258;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;259;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;260;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;261;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;262;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;263;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;264;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;265;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;266;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;267;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;268;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;269;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;270;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;271;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;272;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;273;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;274;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;275;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;276;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;277;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;278;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;279;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;280;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;281;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;282;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;283;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;284;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;285;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;286;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;287;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;288;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;289;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;290;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;291;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;292;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;293;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;294;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;295;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;296;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;297;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;298;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;299;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;300;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;301;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;302;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;303;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;304;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;305;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;306;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;307;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;308;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;309;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;310;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;311;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;312;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;313;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;314;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;315;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;316;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;317;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;318;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;319;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;320;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;321;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;322;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;323;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;324;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;325;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;326;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;327;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;328;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;329;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;330;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;331;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;332;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;333;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;334;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;335;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;336;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;337;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;338;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;339;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;340;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;341;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;342;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;343;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;344;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;345;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;346;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;347;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;348;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;349;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;350;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;351;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;352;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;353;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;354;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;355;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;356;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;357;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;358;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;359;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;360;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;361;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;362;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;363;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;364;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;365;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;366;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;367;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;368;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;369;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;370;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;371;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;372;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;373;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;374;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;375;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;376;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;377;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;378;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;379;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;380;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;381;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;382;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;383;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;384;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;385;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;386;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;387;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;388;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;389;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;390;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;391;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;392;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;393;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;394;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;395;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;396;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;397;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;398;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;399;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;400;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;401;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;402;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;403;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;404;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;405;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;406;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;407;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;408;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;409;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;410;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;411;;
11;Tantalizing dilemma in risk prediction from disease scoring statistics.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;7;412;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;1;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;2;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;3;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;4;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;5;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;6;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;7;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;8;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;9;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;10;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;11;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;12;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;13;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;14;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;15;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;16;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;17;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;18;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;19;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;20;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;21;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;22;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;23;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;24;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;25;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;26;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;27;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;28;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;29;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;30;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;31;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;32;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;33;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;34;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;35;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;36;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;37;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;38;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;39;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;40;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;41;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;42;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;43;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;44;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;45;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;46;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;47;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;48;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;49;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;50;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;51;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;52;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;53;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;54;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;55;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;1;56;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;57;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;58;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;59;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;60;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;61;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;62;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;63;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;64;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;65;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;66;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;67;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;68;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;69;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;70;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;71;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;72;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;73;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;74;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;75;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;76;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;77;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;78;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;79;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;80;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;81;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;82;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;83;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;84;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;85;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;86;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;87;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;88;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;89;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;90;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;91;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;92;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;93;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;94;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;95;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;96;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;97;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;98;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;99;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;100;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;101;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;102;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;103;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;104;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;105;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;106;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;107;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;108;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;109;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;110;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;111;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;112;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;113;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;114;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;2;115;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;116;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;117;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;118;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;119;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;120;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;121;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;122;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;123;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;124;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;125;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;126;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;127;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;128;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;129;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;130;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;131;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;132;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;133;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;134;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;135;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;136;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;137;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;138;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;139;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;140;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;141;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;142;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;143;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;144;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;145;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;146;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;147;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;148;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;149;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;150;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;151;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;152;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;153;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;154;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;155;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;156;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;157;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;158;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;159;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;160;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;161;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;162;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;163;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;164;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;165;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;166;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;167;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;168;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;169;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;170;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;171;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;172;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;173;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;3;174;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;175;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;176;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;177;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;178;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;179;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;180;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;181;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;182;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;183;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;184;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;185;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;186;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;187;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;188;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;189;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;190;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;191;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;192;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;193;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;194;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;195;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;196;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;197;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;198;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;199;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;200;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;201;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;202;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;203;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;204;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;205;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;206;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;207;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;208;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;209;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;4;210;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;211;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;212;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;213;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;214;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;215;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;216;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;217;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;218;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;219;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;220;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;221;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;222;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;223;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;224;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;225;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;226;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;227;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;228;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;229;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;230;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;231;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;232;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;233;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;234;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;235;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;236;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;237;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;238;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;239;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;240;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;241;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;242;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;243;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;244;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;245;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;246;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;247;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;248;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;249;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;250;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;251;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;252;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;253;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;254;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;255;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;256;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;257;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;258;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;259;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;260;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;261;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;262;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;263;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;264;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;265;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;266;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;267;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;268;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;269;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;5;270;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;271;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;272;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;273;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;274;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;275;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;276;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;277;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;278;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;279;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;280;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;281;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;282;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;283;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;284;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;285;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;286;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;287;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;288;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;289;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;290;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;291;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;292;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;293;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;294;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;295;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;296;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;297;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;298;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;299;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;300;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;301;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;302;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;303;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;304;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;305;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;306;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;307;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;308;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;309;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;310;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;311;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;312;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;313;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;314;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;315;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;316;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;317;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;318;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;319;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;320;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;321;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;322;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;323;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;324;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;325;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;326;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;327;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;328;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;329;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;330;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;331;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;332;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;333;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;334;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;335;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;336;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;337;;
12;Variant to Gene Mapping to Discover New Targets for Immune Tolerance.pdf;proteomics|transcriptomics|RNA|miRNA|lipidomics|metabolomics|16|microbiome|metagenomics|genomics|DNA seq|;6;338;;
